Summar~
Rat renal slices were incubated in two different media.
One was a normal K, physiological saline solution and the other a high K medium. Renin release was measured every 15 min in the presence and absence of 10-6M isoproterenol and also in the presence and absence of aspirin, 0.8 or 1.6 XI0-5M.
In all experiments renin release was linear during the 75 min of incubation.
Isoproterenol increased renin release by approximately 100%. This was the case even in the presence of aspirin which significantly inhibited prostaglandin release (PGE2, PGF 2 n and 6-keto-PGF 1 ~ ).
Nor was there any reduction in the basal secretory rate by aspirin alone. These data are taken to indicate that aspirin in pharmacological doses does not interfere with either in vitro basal release rates of ten]n, nor the response to B agonists.
It is also suggested that B agonists do not exert their effect by stimulating prostaglandin secretion.
Among the many stimuli that may alter the renal secretory rate of renin are adrenoreceptor agonists (i,2) in vivo in rats and dogs (7, 8) , isolated perfused rabbit kidney (9) and on isolated rat glomeruli (10).
Thus it is not clear what [elation exists between the two systems.
This study was undertaken in an attempt to obtain more informaton concerning this controversy.
We have used rat renal cortical slices as the experimental model and aspirin as the drug of choice for inhibition of PG synthesis.
It has fewer side effects than the more potent inhibitors of PG synthesis, meclofenamate and indomethecin.
Indomethecin has the additional disadvantage of being a drug which may affect intracellular concentrations of Ca (ll). Isoproterenol (ISP) was used as the ~ agonist to stimulate renin release from the slices.
The rates of release for both renin and prostaglandins were measured in all our experiments.
In addition, we have used two experimental models.
Slices were incubated in solutions containing low (normal) K concentrations, or in high K solutions which reduce the basal secretory rate of renin (12 At the end of the incubation period, the slices were quickly removed, blotted and weighed. The medium in each flask was also stored at -20Oc for prostaglandin (PG) assays.
Since the volume of media needed for PG assay was large compared to that for renin, only the 75 min value was obtained.
The incubation solution was of 2 kinds, normal K + (4.7 mM) and high K (35 mM).
In The concentration of isoproterenol used to stimulate renin secretion was 10-6M. Prostaglandin synthesis was inhibited by addition of aspirin (acetyl salicylic powder) to make a final concentration of either 0.8 or 1.6 x 10-5M.
The concentrations selected were the highest therapeutic level recommended, beyond which toxicity may be expected, 150-300 mg/ml, or 0.8 -1.6 X 10-5M (13). The stock solution was titrated with NaOH until the aspirin completely dissolved (fluid pH 7.5-7.8).
ISP was added at zero time, and aspirin at 15 min, so that we could verify that the tissue was viable during the first 15 min.
This method allowed us to obtain curves showing the rate of release. If aspirin had an effect on renin release, it would be manifest by a change in slope.
The frozen incubation media were thawed and centrifuged at 4°C. Five to 30 ul of the media were added to 333 ul of diluted rat renin substrate and the mixture was incubated at 37Oc for l0 and 20 min to determine renin activity as previously reported (2) .
Angiotensin I generated in the mixture was measured by the method of Haber et al. (14) , using a New England Nuclear angiotensin I radioimmunoassay kit. Renin released into the medium is expressed as ng angiotensin I generated per mg kidney slice weight per hour (ng AI/mg-hr) The 75 min values were compared using Student's t test.
Results Figure I shows the results using the normal K medium.
The rate of renin release was linear in all experiments, for all groups.
In addition, it is evident that aspirin (0.8 X 10-5M) had no effect on the basal rate of renin release, nor on the ISP stimulated rate.
In the absence and presence of aspirin ISP significantly stimulated renin secretion by 110% and 155% respectively.
Although the ISP stimulation was slightly greater in the presence of aspirin that difference was not statistically significant (P=.4).
In contrast to the data for renin those for prostaglandin showed a significant reduction of PGE2, PGF 2 ,~ and 6-keto-PGFl e release on aspirin treatment (Table I) .
In N=I8 for control and aspirin groups. N=I2 for ISP and ISP+aspirin groups.
The concentration of aspirin was 0.8 X 10-5M.
Data for the experiments using high K PSS are shown in Figure 2 . For convenience the rate of another series incubated in normal K PSS is also shown.
High K reduced the basal secretory rate to 41% of that in normal K PSS.
No change in slope is evident between slices incubated in high K media, ISP with or without aspirin.
At 75 mln ISP stimulated the renin secretory rate 103% and 75% in the absence and presence of 1.6 x 10-5M aspirin.
The difference was not significant (P <.25). Furthermore, no change in slope is evident after aspirin.
However, aspirin reduced all three prostaglandin release rates significantly.
The concentration of K in the medium did not effect PG release, nor did ISP alone (P < .2 for both PGE 2 and PGF 2 ~ and .5 for 6-keto PGF 1 a ). Table  II shows the prostaglandin release rates for those experiments. (19) . In both situations the results were the same. Aspirin significantly inhibited the release, and presumably the synthesis of PGE2, PGF 2 n and 6-keto-PGF l n • However, in spite of the 8ignlflcant inhibition of PG synthesis, no effect on the basal secretory rate of renin release, or on the ISP stimulation of renln release was noted. Since these experiments are uncomplicated by alterations in baroreceptor stimulation, we believe no evidence is apparent to conclude that B agonlsts affect renin secretion by first causing an Increased release of PGs.
It should also be noted that PG synthesis did not vary with basal renin secretory rates. Renln release varied by a factor of two in high vs. low K media, but PG release was virtually identical.
Although in these experiments PG release appears to have no significant effect on renin release, there are other situations In which they seem to be related (3) (4) (5) (6) . We conclude that whatever the mechanism of in vitro ISP stimulation of renln release is, it is independent of prostaglandin synthesis.
